Works matching DE "IMMUNE checkpoint inhibitors"

Results: 5000

TACE Empowers Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors in Unresectable HCC: A Multicenter Retrospective Study.

Published in:

Journal of Cancer, 2025, v. 16, n. 8, p. 2750, doi. 10.7150/jca.112706

By:

Yu Lei;
Yaowei Bai;
Xiatong Bai;
Jiacheng Liu;
Bo Sun;
Wenlong Wu;
Xiaoling Zhi;
Yang Su;
Hongsen Zhang;
Chuansheng Zheng

Publication type:

Article

Immunotherapy for triple-negative breast cancer: current trends and future prospects.

Published in:

Journal of the Egyptian National Cancer Institute, 2025, v. 37, n. 1, p. 1, doi. 10.1186/s43046-025-00295-x

By:

Essalihi, Amina;
Bouchra, Oumaima;
Khadiri, Khadija;
Khadrouf, Zineb;
Karkouri, Mehdi

Publication type:

Article

Lymphatic dissemination of HPV-positive oropharyngeal squamous cell carcinoma: underlying mechanisms and treatment innovations.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1601572

By:

Li, Xinyu;
Qiu, Hui;
Wu, Qiuji

Publication type:

Article

The comparison of efficacy and safety between cadonilimab (PD-1/CTLA-4) and anti-PD-1 inhibitors in patients with recurrent or metastatic cervical cancer: a retrospective real-world study.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1582299

By:

Pan, Baoyue;
Huang, He;
Wan, Ting;
Huang, Qidan;
He, Shanyang;
Xu, Shijie;
Chen, Siyu;
Yin, Jiaxin;
Li, Jundong;
Zheng, Min

Publication type:

Article

免疫检查点抑制剂联合抗血管生成药物治疗晚期非小细胞肺癌的研究进展.

Published in:

Cancer Research on Prevention & Treatment, 2025, v. 52, n. 6, p. 527, doi. 10.3971/j.issn.1000-8578.2025.24.1280

By:

曾爱菊;
马代远

Publication type:

Article

Neurological and Cardiac Adverse Events in Cervical Cancer Treatment: A Case of Postoperative Sintilimab-Induced Encephalitis and Myocarditis.

Published in:

2025

By:

Haiyu Guo;
Huanlei Wu;
Jun Li;
Runchao Li

Publication type:

Case Study

Outcomes of concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for melanoma brain metastases.

Published in:

Journal of Neuro-Oncology, 2025, v. 173, n. 3, p. 619, doi. 10.1007/s11060-025-05026-9

By:

Fu, Allen Ye;
Bernstein, Kenneth;
Zhang, Jeff;
Silverman, Joshua;
Mehnert, Janice;
Sulman, Erik P.;
Oermann, Eric Karl;
Kondziolka, Douglas

Publication type:

Article

Immune-related myocarditis characterized by malignant arrhythmia caused by conduction system involvement: case report and literature review.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1589990

By:

Zhan, Luying;
Qin, Zhiquan;
Yang, Liu;
Chen, Yun

Publication type:

Article

Splenic volume as a predictor of survival in cancer patients treated with immune checkpoint inhibitors.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1598484

By:

Zhang, Yunhua;
Fu, Xin;
Zhang, Lilong;
Zhou, Qing;
Wang, Weixing

Publication type:

Article

Case Report: Regenerative hepatic pseudotumor induced by tislelizumab in a lung cancer patient.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1565065

By:

Wang, Wenrui;
Li, Wei;
Zhang, Tianqi;
Jin, Zhenjing;
Yang, Lanlan

Publication type:

Article

Baseline profile peripheral Tfh cells predict immune-related adverse events in immune checkpoint inhibitor therapy of gastrointestinal cancer.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1559275

By:

Wang, Yifan;
Zhang, Zhening;
Xie, Tong;
Liu, Yudong;
Zhang, Cheng;
Li, Hao;
Feng, Ruiling;
Huang, Bo;
Liu, Qinghong;
Wang, Naidi;
Xing, Xiaoyan;
Han, Yipeng;
Li, Xue;
Wang, Ruoyi;
He, Jing;
Peng, Zhi

Publication type:

Article

Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1553882

By:

Ma, Hongfang;
Zhang, Shasha;
Jiao, Pengqing;
Ding, Haixia;
Wang, Fujun;
Zhao, Yue;
Wu, Jianhua;
Guo, Zhanjun

Publication type:

Article

T lymphocyte heterogeneity in NSCLC: implications for biomarker development and therapeutic innovation.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1604310

By:

Liu, Yu;
Qin, Denghui;
Fu, Jiejun

Publication type:

Article

Roles and functions of tumor-infiltrating lymphocytes and tertiary lymphoid structures in gastric cancer progression.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1595070

By:

Yao, Zhiyuan;
Li, Gengchen;
Pan, Di;
Pei, Zichen;
Fang, Yan;
Liu, Haonan;
Han, Zhengxiang

Publication type:

Article

Bispecific antibody for lung cancer: mechanisms and clinical insights.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1572802

By:

Chen, Wei;
Zhou, Afang;
Zhou, Yunfeng

Publication type:

Article

Cosibelimab.

Published in:: American Journal of Health-System Pharmacy, 2025, v. 82, n. 12, p. 638, doi. 10.1093/ajhp/zxaf055
Publication type:: Article

Hepatic artery infusion chemotherapy plus an immune checkpoint inhibitor and lenvatinib for the treatment of biliary tract carcinoma.

Published in:

World Journal of Surgical Oncology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12957-025-03882-3

By:

Wang, Junying;
Zhu, Guangyu;
Guo, Jinhe;
Teng, Gaojun

Publication type:

Article

Unraveling the role of HDAC3 as an immunotherapy prognostic biomarker and therapeutic target in advanced non-small cell lung cancer.

Published in:

Respiratory Research, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12931-025-03275-w

By:

Dai, Liyuan;
Huang, Liling;
Li, Lin;
Tang, Le;
Shi, Yuankai;
Han, Xiaohong

Publication type:

Article

Macrophage Transcriptomic Alterations Driven by Alphavirus‐Based Cancer Immunotherapy Vectors.

Published in:

Journal of Immunology Research, 2025, v. 2025, p. 1, doi. 10.1155/jimr/6573891

By:

Korotkaja, Ksenija;
Lapina, Darija;
Rudevica, Zhanna;
Zajakina, Anna;
Saini, Esha

Publication type:

Article

Organ‐Specific Responses to Nivolumab Plus Ipilimumab in Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study.

Published in:

Cancer Medicine, 2025, v. 14, n. 11, p. 1, doi. 10.1002/cam4.70997

By:

Kim, Jung Sun;
Kim, Youngun;
Kang, Beodeul;
Kim, Ilhwan;
Kim, Hyeyeong;
Lee, Won Suk;
Hong, Jung Yong;
Lim, Ho Yeong;
Kim, Han Sang;
Kim, Chang Gon;
Jung, Sanghoon;
An, Chansik;
Kim, Chan;
Chon, Hong Jae

Publication type:

Article

Integrated Analysis of Single‐Cell and Bulk RNA‐Sequencing Defines N7‐Methylguanosine (m7G)‐Mediated Modifications' Role in Prognosis and the Tumor Immune Microenvironment in Hepatocellular Carcinoma.

Published in:

Cancer Medicine, 2025, v. 14, n. 11, p. 1, doi. 10.1002/cam4.70992

By:

Liang, Jiahua;
Ma, Mingjian;
Xu, Borui;
Zhong, Cheng;
Zeng, Guangyan;
Lu, Huijiao;
Lai, Jiaming;
Chen, Jiancong

Publication type:

Article

Detection of immune-mediated tumour cell death in vivo using Zirconium-89-labeled APOMAB®.

Published in:

Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06684-z

By:

Liapis, Vasilios;
Wittwer, Nicole L.;
Tieu, William;
Gargett, Tessa;
Brown, Michael P.;
Staudacher, Alexander H.

Publication type:

Article

Co-delivery of axitinib and PD-L1 siRNA for the synergism of vascular normalization and immune checkpoint inhibition to boost anticancer immunity.

Published in:

Journal of Nanobiotechnology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12951-025-03170-y

By:

Liu, Yanhong;
Gong, Liming;
Feng, Jing;
Xiao, Congcong;
Liu, Chenfei;
Chen, Bohan;
Chen, Liqing;
Jin, Mingji;
Guan, Youyan;
Gao, Zhonggao;
Huang, Wei

Publication type:

Article

Impact of metabolic and nutritional disorders on the synergy between radiotherapy and immunotherapy in non-small-cell lung cancer.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14278-7

By:

Chen, Haiyan;
Yu, Yaner;
Zhu, Shuangqiu;
Zhao, Jian;
Ma, Yan;
Huang, Zhifei;
Jiang, Hao;
Wei, Qichun

Publication type:

Article

Fatal toxic epidermal necrolysis associated with an immune checkpoint inhibitor.

Published in:

2025

By:

Seki, Chiaki;
Koike, Yuta;
Higuchi, Misato;
Ikenaga, Eri;
Waseda, Tomoka;
Ichiki, Mio;
Ehara, Daisuke;
Takenaka, Motoi;
Kusano, Keiko;
Sonoda, Yuuki;
Murota, Hiroyuki

Publication type:

Letter

A multimodal fusion system predicting survival benefits of immune checkpoint inhibitors in unresectable hepatocellular carcinoma.

Published in:

NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00979-6

By:

Xu, Jun;
Wang, Tengfei;
Li, Junjun;
Wang, Yong;
Zhu, Zhangxiang;
Fu, Xiao;
Wang, Junjie;
Zhang, Zhenglin;
Cai, Wei;
Song, Ruipeng;
Hou, Changlong;
Yang, Li-Zhuang;
Wang, Hongzhi;
Wong, Stephen T. C.;
Li, Hai

Publication type:

Article

Expert consensus on the combination of anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma (2025 edition).

Published in:

China Oncology, 2025, v. 35, n. 5, p. 510, doi. 10.19401/j.cnki.1007-3639.2025.05.010

By:

XUE Liqiong;
XU Tingting;
GUO Ye;
HU Chaosu

Publication type:

Article

Evaluation of the efficacy and safety of TACE combined with anlotinib and sintilimab in the treatment of patient with CNLC stage IIB-IIIB liver cancer.

Published in:

China Oncology, 2025, v. 35, n. 5, p. 478, doi. 10.19401/j.cnki.1007-3639.2025.05.006

By:

TONG Gang;
HUA Yang;
PENG Wei;
ZHAO Ju;
HU Junwen

Publication type:

Article

Editorial: Immune cell therapy approaches targeting tumor microenvironment.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1628689

By:

Patnaik, Santosh K.;
Kalathil, Suresh Gopi

Publication type:

Article

T cell exhaustion in pediatric B-ALL: current knowledge and future perspectives.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1531145

By:

Atre, Tanmaya;
Reid, Gregor S. D.

Publication type:

Article

Experiences of Cutaneous Immune‐Related Adverse Events: A Qualitative Study in Patients With Cancer Receiving Immune Checkpoint Inhibitors.

Published in:

Dermatologic Therapy, 2025, v. 2025, p. 1, doi. 10.1155/dth/7119579

By:

Yang, Zhihui;
Lu, Ruiqi;
Li, Xingwen;
Liu, Suting;
Luo, Yuanyuan;
Wang, Ziqi;
Zhao, Yang;
Zhang, Lili;
Pimpinelli, Nicola

Publication type:

Article

Delineation of monocytic and early‐stage myeloid‐derived suppressor cells in the peripheral blood of patients with hepatocarcinoma.

Published in:

International Journal of Cancer, 2025, v. 156, n. 12, p. 2416, doi. 10.1002/ijc.35390

By:

Chivite‐Lacaba, Marta;
Justo, Iago;
Utrero‐Rico, Alberto;
Caso, Oscar;
González‐Cuadrado, Cecilia;
Del Rey, Manuel J.;
Laguna‐Goya, Rocio;
Arroyo‐Ródenas, Javier;
Alfocea‐Molina, Ángel;
Ruigómez‐Martín, Carlota C.;
Serrano, Manuel;
Pascual‐Palacios, Lorena;
Mancebo, María Esther;
Paz‐Artal, Estela

Publication type:

Article

How many people in the US are eligible for and respond to checkpoint inhibitors: An empirical analysis.

Published in:

International Journal of Cancer, 2025, v. 156, n. 12, p. 2352, doi. 10.1002/ijc.35347

By:

Haslam, Alyson;
Olivier, Timothée;
Prasad, Vinay

Publication type:

Article

基于噬菌体展示技术的替雷利珠单抗特异性结合肽筛选鉴定及其应用研究.

Published in:

Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2025, v. 25, n. 5, p. 513, doi. 10.14009/j.issn.1672-2124.2025.05.001

By:

陈雨;
樊芳;
袁智龙;
张雨欣;
王卓

Publication type:

Article

Predicting 30-Day Cardiotoxicity in Patients Receiving Immune Checkpoint Inhibitors: An Observational Study Utilizing XGBoost.

Published in:

Cardiovascular Toxicology, 2025, v. 25, n. 7, p. 994, doi. 10.1007/s12012-025-09990-6

By:

Li, Jialian;
Chen, Zulu;
Zhu, Yuxi;
Li, Gui;
Li, Yanwei;
Lan, Rui;
Zuo, Zhong

Publication type:

Article

Correction to: Predicting 30-Day Cardiotoxicity in Patients Receiving Immune Checkpoint Inhibitors: An Observational Study Utilizing XGBoost.

Published in:

2025

By:

Li, Jialian;
Chen, Zulu;
Zhu, Yuxi;
Li, Gui;
Li, Yanwei;
Lan, Rui;
Zuo, Zhong

Publication type:

Correction Notice

Impaired Overall Survival of Melanoma Patients Due to Antibiotic Use Prior to Immune Checkpoint Inhibitor Therapy: Systematic Review and Meta-Analysis.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1872, doi. 10.3390/cancers17111872

By:

Gambichler, Thilo;
Weyer-Fahlbusch, Sera S.;
Overbeck, Jan;
Abu Rached, Nessr;
Becker, Jürgen C.;
Susok, Laura

Publication type:

Article

Surgical Management of Renal Cell Carcinoma in Transplanted Kidneys—A Narrative Review.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1864, doi. 10.3390/cancers17111864

By:

Moldoveanu, Oana;
Baston, Cătălin;
Preda, Adrian Traian;
Sorohan, Bogdan;
Stoica, Robert;
Mirvald, Cristian;
Sinescu, Ioanel

Publication type:

Article

Bridging Immune Evasion and Vascular Dynamics for Novel Therapeutic Frontiers in Hepatocellular Carcinoma.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1860, doi. 10.3390/cancers17111860

By:

Wu, Sulin;
Anand, Namrata;
Guo, Zhoubo;
Li, Mingyang;
Santiago Figueroa, Marcos;
Jung, Lauren;
Kelly, Sarah;
Franses, Joseph W.

Publication type:

Article

Immunotherapy for High-Grade Gliomas.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1849, doi. 10.3390/cancers17111849

By:

Karbhari, Nishika;
Frechette, Kelsey M.;
Burns, Terry C.;
Parney, Ian F.;
Campian, Jian L.;
Breen, William G.;
Sener, Ugur T.;
Lehrer, Eric J.

Publication type:

Article

The Era of Precision Medicine: Advancing Treatment Paradigms for Small Cell Lung Cancer.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1847, doi. 10.3390/cancers17111847

By:

Corica, Derek A.;
Bell, Scott D.;
Zhao, Lei;
Lawler, Nicholas J.;
Poirier, McKade A.;
Miller, Peyton J.;
Wakefield, Mark R.;
Fang, Yujiang

Publication type:

Article

Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1845, doi. 10.3390/cancers17111845

By:

Arnold, Lisa;
Morak, Monika;
Kramer, Nora;
Berking, Carola;
Schefzyk, Matthias;
Hassel, Jessica C.;
Ziemer, Mirjana;
French, Lars E.;
Gutzmer, Ralf;
Nashan, Dorothee;
Heinzerling, Lucie

Publication type:

Article

Immune Checkpoint Inhibitors in the Treatment of Advanced Melanoma in Older Patients: An Overview of Published Data.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1835, doi. 10.3390/cancers17111835

By:

Lens, Marko;
Schachter, Jacob

Publication type:

Article

A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1829, doi. 10.3390/cancers17111829

By:

Burcher, Kimberly;
Karukonda, Pooja;
Kelsey, Christopher;
Mullikin, Trey;
Antonia, Scott J.;
Oduah, Eziafa I.

Publication type:

Article

T-Cell Engager Therapy in Prostate Cancer: Molecular Insights into a New Frontier in Immunotherapy.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1820, doi. 10.3390/cancers17111820

By:

Kwon, Whi-An;
Joung, Jae Young

Publication type:

Article

Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1817, doi. 10.3390/cancers17111817

By:

Goh, Nicole Lisa Li-Ann;
Abdul Rahim, Nur Jannah;
Bhatt, Rituparna;
Ong, Si En;
Lim, Khai Yee;
Gandini, Anastasia;
Zeng, Zhen;
Kumari, Snehlata;
Gabrielli, Brian

Publication type:

Article

Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1790, doi. 10.3390/cancers17111790

By:

Moiseenko, Fedor;
Radulovic, Marko;
Tsvetkova, Nadezhda;
Chernobrivceva, Vera;
Gabina, Albina;
Oganesian, Any;
Makarkina, Maria;
Elsakova, Ekaterina;
Krasavina, Maria;
Barsova, Daria;
Artemeva, Elizaveta;
Khenshtein, Valeria;
Levchenko, Natalia;
Chubenko, Viacheslav;
Egorenkov, Vitaliy;
Volkov, Nikita;
Bogdanov, Alexei;
Moiseyenko, Vladimir

Publication type:

Article

CD300a: An Innate Immune Checkpoint Shaping Tumor Immunity and Therapeutic Opportunity.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1786, doi. 10.3390/cancers17111786

By:

Peng, Jei-Ming;
Liu, Hui-Ying

Publication type:

Article

Regulatory Mechanisms and Therapeutic Targeting of PD-L1 Trafficking and Stability in Cancer Immunotherapy.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1747, doi. 10.3390/cancers17111747

By:

Mani, Muralidharan;
Park, Jeong Woo;
Martin, Thomas F. J.

Publication type:

Article

The Current State of Tumor Microenvironment-Specific Therapies for Non-Small Cell Lung Cancer.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1732, doi. 10.3390/cancers17111732

By:

Chandra, Raghav;
Ehab, Jasmina;
Hauptmann, Edward;
Gunturu, Naga Swati;
Karalis, John D.;
Kent, Daniel O.;
Heid, Christopher A.;
Reznik, Scott I.;
Sarkaria, Inderpal S.;
Huang, Huocong;
Brekken, Rolf A.;
Minna, John D.

Publication type:

Article